Aptinyx Presents Preclinical and Phase 1 Clinical Data on NYX-2925 at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics by Seini Moimoi | Mar 8, 2018 | Uncategorized
Rapid Micro Biosystems Appoints Natale “Nat” Ricciardi to Board of Directors by longitudeadmin | Mar 15, 2016 | Uncategorized
CardioDx Receives College of American Pathologists (CAP) Accreditation by longitudeadmin | May 9, 2013 | Uncategorized
Longitude Capital Beats Target for Fund II, Raises $385M for Biotech, Medtech Deals by longitudeadmin | Oct 10, 2012 | Uncategorized
